| Susannah Holden, LCSW | |
|
4983 W Amethyst Dr, West Jordan, UT 84081-2905 | |
| (801) 660-7194 | |
| Not Available |
| Full Name | Susannah Holden |
|---|---|
| Gender | Female |
| Speciality | Social Worker - Clinical |
| Location | 4983 W Amethyst Dr, West Jordan, Utah |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003678939 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 6652876-3501 (Utah) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Susannah Holden, LCSW 4983 W Amethyst Dr, West Jordan, UT 84081-2905 Ph: (801) 660-7194 | Susannah Holden, LCSW 4983 W Amethyst Dr, West Jordan, UT 84081-2905 Ph: (801) 660-7194 |
News Archive
A new study finds that while colorectal cancer mortality rates dropped in the most recent two decades for every stage in both African Americans and whites, the decreases were smaller for African Americans, particularly for distant stage disease.
Since the coronavirus disease 2019 (COVID-19) outbreak was identified in Wuhan, China, in December 2019, many countries have introduced restrictive measures to curb the circulation and spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
The fatality rate among infected people increases among the elderly and those with underlying medical conditions. Now, a new study published as a pre-print on medXriv, links smoking to the progression of COVID-19 disease, suggesting that the odds of disease progression is more than double in smokers.
Dr. Jay Kulkin, MD, internationally recognized laser expert and Fellow of the American Society for Laser Medicine and Surgery (highest designation), has successfully developed a laser technique making laser hair removal burns in ethnic skin types a thing of the past.
Aerpio Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on advancing innovative therapies for vascular diseases, today announced that it has dosed the first patient in a Phase 2 trial evaluating AKB-9778, a Tie2 activator, alone and in combination with ranibizumab (Lucentis) for the treatment of diabetic macular edema (DME). AKB-9778 is a first-in-class inhibitor of human protein tyrosine phosphatase beta (HPTPβ) that activates the Tie2 pathway to promote vascular stability, preventing abnormal blood vessel growth and vascular leak.
› Verified 2 days ago
Mr. Spencer Giles Morgan, MSW LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 9253 B Redwood Rd, West Jordan, UT 84088 Phone: 801-566-4079 | |
Chelsey Tautkus, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 7601 South Redwood Road,, Building E, West Jordan, UT 84084 Phone: 801-233-8670 Fax: 801-233-8682 | |
Jessie Ann Ritchey, APRN Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 7181 S Campus View Dr Ste 1a, West Jordan, UT 84084 Phone: 801-613-9843 | |
Janaka Vander Kooi, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 9263 Redwood Rd Bldg 8, West Jordan, UT 84088 Phone: 801-566-0749 Fax: 801-566-7108 | |
David Burrows, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 8783 S Redwood Rd Ste C, West Jordan, UT 84088 Phone: 435-799-5035 Fax: 435-535-3782 | |
Carolyn Memmott, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 8537 S Redwood Rd Ste C2, West Jordan, UT 84088 Phone: 801-829-9726 |